Vaste Pagina`s - Voor 30 november post-p

Cover Page
The handle http://hdl.handle.net/1887/31819 holds various files of this Leiden University
dissertation.
Author: Gao, Linda
Title: Promoter CpG island hypermethylation in the development of cutaneous
melanoma
Issue Date: 2015-02-04
Promoter CpG island hypermethylation in the
development of cutaneous melanoma
Proefschrift
ter verkrijging van
de graad van Doctor aan de Universiteit Leiden,
op gezag van Rector Magnificus prof.mr. P.F. van der Heijden,
volgens besluit van het College voor Promoties
te verdedigen op woensdag 4 februari 2015
klokke 16.15 uur
door
Linda Gao
geboren te Beijing
in 1984
Promoter CpG island hypermethylation in the development of cutaneous melanoma
Financial support for the publication of this thesis was kindly provided by Galderma Benelux B.V.
ISBN: 978-90-5335-987-7
Printed by Ridderprint B.V.
Promoter CpG island hypermethylation in the
development of cutaneous melanoma
Proefschrift
ter verkrijging van
de graad van Doctor aan de Universiteit Leiden,
op gezag van Rector Magnificus prof.mr. C.J.J.M. Stolker,
volgens besluit van het College voor Promoties
te verdedigen op woensdag 4 februari 2015
klokke 16.15 uur
door
Linda Gao
geboren te Beijing
in 1984
Promotiecommissie
Promotor
Prof.dr. R. Willemze
Co-promotor
Dr. R. van Doorn
Overige leden
Prof.dr. J.J. van den Oord
Catholic University Leuven (KU Leuven), Leuven, Belgium
Prof.dr. W.J. Mooi
VU University Medical Center (VUmc), Amsterdam
Prof.dr.ir. S.M. van der Maarel
Table of contents
Abbreviations
9
Chapter 1 General introduction
11
Chapter 2 Genome-wide promoter methylation analysis identifies
epigenetic silencing of MAPK13 in primary cutaneous melanoma
29
Pigment Cell & Melanoma Research 2013; 26(4):542-54
Chapter 3 Near-genomewide RNAi screening for regulators of BRAFV600E-induced
senescence identifies RASEF, a gene epigenetically silenced in melanoma
61
Pigment Cell & Melanoma Research 2014; 27(4):640-52
Chapter 4 Promoter CpG island hypermethylation in dysplastic naevus
and melanoma: CLDN11 as an epigenetic biomarker for malignancy
87
Journal of Investigative Dermatology 2014; 10.1038/jid.2014.270
Chapter 5 Genome-wide analysis of gene and protein expression of dysplastic
naevus cells
109
Journal of Skin Cancer 2012; 2012: 981308
Chapter 6 Promoter CpG island hypermethylation of MCHR1 and SYNPO2
in primary cutaneous melanoma with metastatic behavior
131
Manuscript in preparation
Chapter 7 Summary and Discussion
Nederlandse samenvatting
Curriculum vitae
145
161
167
Abbreviations
AJCC
American Joint Committee on Cancer
BMCA
bisulphite melting curve analysis
BRAF
B-Raf proto-oncogene, serine/threonine kinase
BrdU
5-bromo-2´-deoxyuridine
BSA
bisulphite sequencing analysis
C10rf106
chromosome 1 open reading frame 106
CDH1
cadherin 1, type 1, E-cadherin (epithelial)
CDH11
cadherin 11, type 2, OB-cadherin (osteoblast)
CDKN2A
cyclin-dependent kinase inhibitor 2A
CLDN11
claudin 11
CpG
cytosine-phosphate-guanine dinucleotide in linear sequence
CPSF6
cleavage and polyadenylation specific factor 6,68kDa
D176A
aspartic acid at amino acid 176 replaced by alanine, MAPK13 mutant
DNMT
DNA (cytosine-5-)-methyltransferase
EFCAB1
EF-hand calcium binding domain 1
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
F324S
phenylalanine at amino acid 324 replaced by serine, MAPK13 mutant
FAMMM
familial atypical multiple mole melanoma
HDAC
histone deacetylase
HIST1H3E
histone cluster 1, H3e
HOXA9
homeobox A9
LEP
leptin
MAGEA
melanoma antigen family A
MAGEB
melanoma antigen family B
MAPK13
mitogen-activated protein kinase 13
MBD
methyl-CpG-binding domain proteins
MCHR1
melanin-concentrating hormone receptor 1
MeCP2
methyl CpG binding protein 2
MeDIP
methylated DNA immune precipitation
MITF
microphthalmia-associated transcription factor
NRAS
neuroblastoma RAS viral (v-ras) oncogene homolog
OIS
oncogene-induced senescence
p38δ
p38 MAP kinase protein, isoform δ
PLEKHG6
pleckstrin homology domain containing, family G (with RhoGef domain) member 6
PPP1R3C
protein phosphatase 1, regulatory subunit 3C
RASEF
RAS and EF-hand domain containing
Rb
retinoblastoma protein
ROS
reactive oxygen species
SYNPO2
synaptopodin 2 (myopodin)
TBP
TATA box binding protein
TIMP3
TIMP metallopeptidase inhibitor 3
TNM
tumor depth (T), lymph node status (N), and distant metastasis (M) classification
V600E
valine at amino acid 600 replaced by glutamic acid, BRAF mutant
9
10